Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$4.955
−$0.165 · -3.22%
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Regular session
$4.955
−$0.165 · -3.22%
Regular session · ET · Market data may be delayed.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Day range
Current $4.955
52-week range
Current $4.955
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
85
Deep Value
Sentiment
64
Bullish
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
Day range
Current $4.955
52-week range
Current $4.955
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.08B USD | 1.12B USD | 1.12B USD | 1.13B USD | 1.17B USD |
| Cost of goods sold | 400.9M USD | 394.2M USD | 370.9M USD | 354.6M USD | 365M USD |
| Gross profit | 679.5M USD | 728.9M USD | 749.9M USD | 774.9M USD | 800M USD |
| Research and development | 21.5M USD | 78.8M USD | 85.2M USD | 65M USD | 63M USD |
| Selling, general, and administrative | 331.4M USD | 365.1M USD | 341.3M USD | 294.8M USD | 240.3M USD |
| Operating expenses | 350.2M USD | 554.7M USD | 520.3M USD | 396.8M USD | 308M USD |
| Interest expense | 107.3M USD | 112.3M USD | 107M USD | 46.2M USD | — |
| Depreciation and amortization | 51.1M USD | 42.5M USD | 32.7M USD | 31.7M USD | 38M USD |
| Operating income | 329.3M USD | 174.2M USD | 229.6M USD | 378.1M USD | 492M USD |
| Net income | 95.4M USD | 78.3M USD | 70.4M USD | 223.6M USD | 414.8M USD |
Company facts updated Sep 10, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$0.60
2025 complete year0.0% since 2023
2026 partial: $0.17
$0.60
2,023
$0.60
2,024
$0.60
2,025
$0.17
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 27, 2026 | $0.01Quarterly | Aug 27, 2026 | Sep 15, 2026 |
Dividend | May 28, 2026 | $0.01Quarterly | May 28, 2026 | Jun 15, 2026 |
Dividend | Feb 27, 2026 | $0.15Quarterly | Feb 27, 2026 | Mar 17, 2026 |
Dividend | Dec 5, 2025 | $0.15Quarterly | Dec 5, 2025 | Dec 18, 2025 |
Dividend | Aug 29, 2025 | $0.15Quarterly | Aug 29, 2025 | Sep 15, 2025 |
Dividend | May 28, 2025 | $0.15Quarterly | May 28, 2025 | Jun 13, 2025 |
Ex-dividend Aug 27, 2026
$0.01
Quarterly
Record Aug 27, 2026 · Payment Sep 15, 2026
Ex-dividend May 28, 2026
$0.01
Quarterly
Record May 28, 2026 · Payment Jun 15, 2026
Ex-dividend Feb 27, 2026
$0.15
Quarterly
Record Feb 27, 2026 · Payment Mar 17, 2026
Ex-dividend Dec 5, 2025
$0.15
Quarterly
Record Dec 5, 2025 · Payment Dec 18, 2025
Ex-dividend Aug 29, 2025
$0.15
Quarterly
Record Aug 29, 2025 · Payment Sep 15, 2025
Ex-dividend May 28, 2025
$0.15
Quarterly
Record May 28, 2025 · Payment Jun 13, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM8.16M0.01%80.51B USD0.19%$288.01-0.90%
Vanguard Morningstar Total Stock Market ETFVTI6.67M0.00%2.3T USD0.03%$373.45-0.56%
iShares Russell 2000 Value ETFIWN2.89M0.02%14.61B USD0.24%$218.74-0.79%
Vanguard Extended Market ETFVXF2.55M0.00%93.7B USD0.05%$236.8-0.79%
Schwab Fundamental U.S. Small Company Index ETFFNDA2.15M0.02%8.98B USD0.25%$36.225-0.75%
WisdomTree U.S. SmallCap Dividend FundDES1.95M0.09%2.16B USD0.38%$39.51-0.70%
Schwab U.S. Small-Cap ETFSCHA1.42M0.01%22.62B USD0.03%$33.685-1.22%
Vanguard Russell 2000 ETFVTWO1.21M0.01%17.4B USD0.06%$116.43-0.92%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 Value ETFIWNVanguard Extended Market ETFVXFSchwab Fundamental U.S. Small Company Index ETFFNDAWisdomTree U.S. SmallCap Dividend FundDESSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
